Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hypoxia × Blood Specimen Collection × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 51 Neoplasms 48 Lung Neoplasms 30 Colorectal Neoplasms 28 Carcinoma, Non-Small-Cell Lung 23 Prostatic Neoplasms 19 Melanoma 19 Pancreatic Neoplasms 15 Ovarian Neoplasms 14 Multiple Myeloma 12 Sarcoma 11 Lymphoma 11 Uterine Cervical Neoplasms 10 Neoplasm Metastasis 10 Leukemia, Myeloid, Acute 10 Glioblastoma 10 Colonic Neoplasms 10 Hematologic Neoplasms 9 Neoplastic Cells, Circulating 8 Head and Neck Neoplasms 8 Glioma 8 Lymphoma, Follicular 7 Leukemia 7 Carcinoma, Hepatocellular 7 Myelodysplastic Syndromes 6 Disease 6 Brain Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Papillomavirus Infections 5 Kidney Neoplasms 5

Interventions

3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 5 TH 302 4 pimonidazole 3 fluoroazomycin arabinoside 3 Radiotherapy 3 Propofol 3 Injections 3 pomalidomide 1 gadobutrol 1 fluoromisonidazole 1 fludarabine 1 Tirapazamine 1 Temozolomide 1 Sodium Chloride 1 Sevoflurane 1 Saline Solution 1 Pancreaticoduodenectomy 1 Oxygen 1 Nitroglycerin 1 Nimorazole 1 Magnetic Resonance Spectroscopy 1 Ketamine 1 Ipilimumab 1 Hydroxychloroquine 1 Gemcitabine 1 Furosemide 1 Ferrosoferric Oxide 1 Exercise 1 Ethiodized Oil 1 Diagnostic Imaging 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02157246 2017-03-13

RHYTHM-I

University of Oxford

Phase NA Completed

Gastrointestinal

Hypoxia, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡